A new publication from ANA president David Holtzman, MD summarizes increases in our understanding of the involvement of TREM2 and microglia in Alzheimer's disease development that may open new therapeutic strategies targeting the immune system to influence AD pathogenesis.
Learn more: New insights into the role of TREM2 in Alzheimer’s disease